Skip to main content
. 2018 Feb 12;39(4):1649–1657. doi: 10.3892/or.2018.6259

Figure 5.

Figure 5.

miR-199a-3p enhances CDDP sensitivity of ovarian cancer in vivo. (A) Representative images of tumor xenografts, (B) the tumor volumes and (C) the tumor weight were measured at 10 weeks. (D) Representative images of peritoneal metastasis nodules, and the number of peritoneal metastasis (E) in the two groups. (F-H) The expression of miR-199a-3p and IGTB8 in the xenografts were examined by q-PCR and western blotting. Data shown are mean ± SD, *P<0.05, compared with miR-NC (Student's t-test).